Form 8-K - Current report:
SEC Accession No. 0001193125-24-240485
Filing Date
2024-10-21
Accepted
2024-10-21 17:00:56
Documents
14
Period of Report
2024-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d836608d8k.htm   iXBRL 8-K 39493
  Complete submission text file 0001193125-24-240485.txt   214842

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acab-20241016.xsd EX-101.SCH 4157
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acab-20241016_def.xml EX-101.DEF 14516
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acab-20241016_lab.xml EX-101.LAB 24193
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acab-20241016_pre.xml EX-101.PRE 15614
16 EXTRACTED XBRL INSTANCE DOCUMENT d836608d8k_htm.xml XML 7431
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Atlantic Coastal Acquisition Corp. II (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 241384016
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)